Literature DB >> 23722868

Modulation of Treg cells/T effector function by GITR signaling is context-dependent.

Amal Ephrem1, Alan L Epstein, Geoffrey L Stephens, Angela M Thornton, Deborah Glass, Ethan M Shevach.   

Abstract

Treg cells express high levels of the glucocorticoid-induced tumor necrosis factor-related receptor (GITR), while resting conventional T (Tconv) cells express low levels that are increased upon activation. Manipulation of GITR/GITR-Ligand (GITR-L) interactions results in enhancement of immune responses, but it remains unclear whether this enhancement is secondary to costimulation of Tconv cells or to reversal of Treg-cell-mediated suppression. Here, we used a nondepleting Fc-GITR-L and combinations of WT and GITR KO Treg cells and Tconv cells to reexamine the effects of GITR stimulation on each subpopulation in both unmanipulated mice and mice with inflammatory bowel disease. Treatment of mice with Fc-GITR-L resulted in significant expansion of Treg cells and a modest expansion of Tconv cells. When RAG KO mice were reconstituted with Tconv cells alone, GITR-L resulted in Tconv-cell expansion and severe inflammatory bowel disease. The protective effect of Treg cells was lost in the presence of Fc-GITR-L, secondary to death of the Treg cells. When RAG KO mice were reconstituted with Treg cells alone, the transferred cells expanded normally, and Fc-GITR-L treatment resulted in a loss of Foxp3 expression, but the ex-Treg cells did not cause any pathology. The effects of GITR activation are complex and depend on the host environment and the activation state of the Treg cells and T effector cells. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Glucocorticoid-induced tumor necrosis factor-related receptor (GITR); Inflammatory bowel disease; T effector cells; Treg cell

Mesh:

Substances:

Year:  2013        PMID: 23722868     DOI: 10.1002/eji.201343451

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

1.  The role of kisspeptin in immune tolerance formation during pregnancy.

Authors:  O L Gorbunova; S V Shirshev
Journal:  Dokl Biol Sci       Date:  2014-08-30

2.  Regulatory T cells in B-cell-deficient and wild-type mice differ functionally and in expression of cell surface markers.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

3.  GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.

Authors:  David A Schaer; Sadna Budhu; Cailian Liu; Campbell Bryson; Nicole Malandro; Adam Cohen; Hong Zhong; Xia Yang; Alan N Houghton; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Immunol Res       Date:  2013-11       Impact factor: 11.151

Review 4.  Regulatory T cells in the treatment of disease.

Authors:  Amir Sharabi; Maria G Tsokos; Ying Ding; Thomas R Malek; David Klatzmann; George C Tsokos
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

5.  Differential expression of T cell-related genes in AMI and SA stages of coronary artery disease.

Authors:  Wenwen Yan; Lemin Wang; Jinfa Jiang; Wenjun Xu; Zhu Gong; Qianglin Duan; Chuanrong Li; Haoming Song; Lin Che; Yuqin Shen; Lin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  Treg functional stability and its responsiveness to the microenvironment.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 7.  A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.

Authors:  Prabhakaran Kumar; Palash Bhattacharya; Bellur S Prabhakar
Journal:  J Autoimmun       Date:  2018-08-31       Impact factor: 7.094

8.  B cells are critical for autoimmune pathology in Scurfy mice.

Authors:  Susanne Aschermann; Christian H K Lehmann; Sidonia Mihai; Georg Schett; Diana Dudziak; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

Review 9.  Immune checkpoint blockade in infectious diseases.

Authors:  Michelle N Wykes; Sharon R Lewin
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

10.  Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.

Authors:  Maninder Sidhu-Varma; David Q Shih; Stephan R Targan
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.